Sacubitril/valsartan versus valsartan in regressing myocardial fibrosis in hypertension: a prospective, randomized, open-label, blinded endpoint clinical trial protocol

Overview of attention for article published in Frontiers in Cardiovascular Medicine, August 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 17 Mendeley

So far, Altmetric has seen 1 X post from an account with 2,794 followers.

New Research: Sacubitril/valsartan versus valsartan in regressing myocardial fibrosis in hypertension: a prospective, randomized, open-label, blinded endpoint clinical trial protocol: Background Diffuse interstitial myocardial fibrosis… #cardiovascular h…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.